Tevadaptor® Publications

Tevadaptor® is scientifically proven to provide safety when working with hazardous drugs, while protecting drug stability. Our studies are peer reviewed and acknowledged in leading journals and/or conferences.

Use of a Closed-system Drug Transfer Device Reduces Contamination with Doxorubicin During Bolus Injection

Tom Marler-Hausen, Chris Holt, Christine Headley and Paul Sessink
Download PDF

Drug sterility is maintained in Luer Lock (LL) syringes fitted with Tevadaptor syringe adaptor lock (SAL) according to NHS yellow cover document (YCD) syringe integrity standards

Alan-Shaun Wilkinson, Michael Allwood, Aleksandra Slawinska, Andrew Johnson, Laima Ozolina. Marc Sutton, Navneet Bhogal, Kate Pegg
Download PDF

Containment performance assessment of closed system drug transfer devices (CSTDs) using the NIOSH draft protocol and 2.5% w/v 1,1,3,3-tetraethylurea (TEU) in water as the challenge agent

Alan-Shaun Wilkinson, Michael Allwood, Aleksandra Slawinska, Andrew Wallace, Rebecca Finnis, Donata Stonkute, Maja Szramowska, Laima Lazdane...
Download PDF

Reduction of Contamination with Antibiotics on Surfaces and in Environmental Air in Three European Hospitals Following Implementation of a Closed-System Drug Transfer Device

Paul J. M. Sessink, Tibor Nyulasi, Emmie L. M. Haraldsson andBranislava Rebic. Annals of Work Exposures and Health, 2019, 1–9.
Learn More

Performance testing protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs

Wilkinson A-S, Allwood MC, Morris CP, Wallace A, Finnis R, Kaminska E, et al. (2018). PLoS ONE 13(10): e0205263.
Learn More

Understanding closed system transfer devices

Christine Clark, Symposium report,, 2017
Download PDF

Responding to drug shortages and rising costs: IV chemotherapy drug use

Ákos Juhász, Gábor Batka & Attila Szűcs, Drugs Ther Perspect (2016) 32:170-176 DOI 10.1007/s40267-016-0285-6
Learn More

Assessment of the containment performance of closed system drug transfer devices (CSTDs) that either employ a mechanically closed physical barrier or air filtration technology – a Universal Test Protocol for assessment of all CSTD technologies

Alan-Shaun Wilkinson, Michael Allwood, Colin Morris, Andrew Wallace, Rebecca Finnis, Ewelina Kaminska, Donata Stonkute, Maja Szramowska, Joe...
Download PDF
Loading more